


Redefining diuretics use in hypertension: why select a thiazide-like diuretic ? Michel Burnier, George Bakris, and Bryan Williams

Pr MICHEL BURNIER, Drs ERIETTA POLYCHRONOPOULOU et GRÉGOIRE WUERZNER

Comment accepter la réduction des cibles tensionnelles au quotidien lorsque plus de la moitié des patients hypertendus traités ont des valeurs de pression au-dessus des « anciennes » cibles ? La publication de nouvelles recommandations relatives au diagnostic de l’hypertension et aux cibles de pression artérielle à atteindre nous replonge régulièrement dans un questionnement quasi lelouchien : Tout ça pour ça ?

Cardiovascular events represent a major cause of death in renal transplant patients [1,2]. Renal transplant recipients also constitute a population at very high risk for progressive graft loss and renal events. Although immunological risk factors play an important role in renal survival, it is less recognized that hypertension is probably the major nonimmunological risk factor for graft loss [2]. Accurate diagnosis of hypertension and adequate control of blood pressure (BP) is considered as a fundamental goal in the management of renal transplant patients to lower their cardiovascular and renal risk. However, diagnosis, treatment and monitoring of hypertension remain suboptimal in most renal transplant patients [3]. This editorial is a call for action aiming at improving hypertension control in the transplant population.